Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NEMOLIZUMAB-ILTO Cause Skin hyperpigmentation? 8 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Skin hyperpigmentation have been filed in association with NEMOLIZUMAB-ILTO. This represents 0.2% of all adverse event reports for NEMOLIZUMAB-ILTO.

8
Reports of Skin hyperpigmentation with NEMOLIZUMAB-ILTO
0.2%
of all NEMOLIZUMAB-ILTO reports
0
Deaths
0
Hospitalizations

How Dangerous Is Skin hyperpigmentation From NEMOLIZUMAB-ILTO?

Of the 8 reports.

Is Skin hyperpigmentation Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NEMOLIZUMAB-ILTO. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does NEMOLIZUMAB-ILTO Cause?

Inappropriate schedule of product administration (826) Product dose omission issue (792) Device malfunction (761) Incorrect dose administered (579) Pruritus (416) Rash (263) Headache (181) Drug ineffective (158) Device leakage (153) Device use issue (120)

What Other Drugs Cause Skin hyperpigmentation?

ADAPALENE (2,811) AVOBENZONE\OCTISALATE\OCTOCRYLENE (2,277) BIMATOPROST (189) AVOBENZONE\HOMOSALATE\OCTINOXATE\OCTISALATE\OXYBENZONE (182) DUPILUMAB (177) MINOCYCLINE (144) LENALIDOMIDE (142) METHOTREXATE (142) CAPECITABINE (136) COLLAGENASE CLOSTRIDIUM HISTOLYTICUM-AAES (120)

Which NEMOLIZUMAB-ILTO Alternatives Have Lower Skin hyperpigmentation Risk?

NEMOLIZUMAB-ILTO vs NEOMYCIN NEMOLIZUMAB-ILTO vs NEORAL NEMOLIZUMAB-ILTO vs NEOSTIGMINE NEMOLIZUMAB-ILTO vs NEOSTIGMINE METHYLSULFATE NEMOLIZUMAB-ILTO vs NEPAFENAC

Related Pages

NEMOLIZUMAB-ILTO Full Profile All Skin hyperpigmentation Reports All Drugs Causing Skin hyperpigmentation NEMOLIZUMAB-ILTO Demographics